Biocompatibility of PMMA membranes in acute and chronic patients with renal failure

Contributions to Nephrology

Volumn 125, Issue , 1999, Pages 65-75

  Manzoni, Celestina ^a   Locatelli, Francesco ^a  

^a A MANZONI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; BIOMATERIAL; CYTOKINE; POLY(METHYL METHACRYLATE);

ACUTE KIDNEY FAILURE; AMYLOIDOSIS; ANEMIA; ANIMAL; ANURIA; ARTIFICIAL MEMBRANE; CHEMISTRY; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; HUMAN; INFECTION; INFLAMMATION; INSTRUMENTATION; METABOLISM; MOLECULAR WEIGHT; MORTALITY; MULTICENTER STUDY; NUTRITIONAL DISORDER; OLIGURIA; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RAT; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; REVIEW; SECRETION; SURVIVAL; TREATMENT OUTCOME;

AMYLOIDOSIS; ANEMIA; ANIMALS; ANURIA; BETA 2-MICROGLOBULIN; BIOCOMPATIBLE MATERIALS; CLINICAL TRIALS; CYTOKINES; HUMANS; INFECTION; INFLAMMATION; KIDNEY FAILURE, ACUTE; KIDNEY FAILURE, CHRONIC; MEMBRANES, ARTIFICIAL; MOLECULAR WEIGHT; MULTICENTER STUDIES; NUTRITION DISORDERS; OLIGURIA; POLYMETHYL METHACRYLATE; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; RATS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0032615935     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (28)

1. Schulman G, Fogo A, Gung A, Badr K, Hakim R: Complement activation retards resolution of acute ischemic renal failure in the rat. Kidney Int 1991;40:1069-1074.
2. Conger JD: Does hemodialysis delay recovery from acute renal failure? Semin Dial 1990;3:146-148.
3. Solez K, Morel-Moroger L, Sraer JD: The morphology of 'acute tubular necrosis in man'. Medicine 1979;58:362-376.
4. Hakim RM, Wingard RL, Parker RA: Effect of the dialysis membrane in the treatment of patients with acute renal failure. N Engl J Med 1994;331:1338-1374.
5. Kaplan AA, Paganini EP, Bosch JP: Effect of the dialysis membrane in acute renal failure. N Engl J Med 1995;332:961.
6. Himmelfarb J, Tolkoff Rubin N, Chandran P, Parker RA, Wingard RL, Hakim R: A multicenter comparison of dialysis membranes in the treatment of acute renal failure requiring dialysis. J Am Soc Nephrol 1998;9:257-266.
7. Valeri A, Radhakrishnan J, Ryan R, Powell D: Biocompatible dialysis membranes and acute renal failure: A study in post-operative acute tubular necrosis in cadaveric renal transplant recipients. Clin Nephrol 1996;46;6:402-409.
8. Kurtal H, Von Herrath D, Schaefer K: Is the choice of membrane important for patients with acute renal failure requiring dialysis? Int J Artif Organs 1994;5:391-394.
9. Cosentino F, Chaff C, Piedmonte M: Risk factors influencing survival in ICU acute renal failure. Nephrol Dial Transplant 1994;9(suppl 4):179-182.
10. Liano F, Pasqual J, Madrid ARF Study Group: Epidemiology of acute renal failure: A prospective, multicenter, community-based study. Kidney Int 1996;50:811-818.
11. Schiffl H, Lang SM, Konig A, Strasser T, Haider MC, Held E: Biocompatible membranes in acute renal failure. Prospective case-controlled study. Lancet 1994; 344:570-572.
12. Schiffl H, Sitter T, Lang S, Konig A, HaiderMC, Held E: Bioincompatible membranes place patients with acute renal failure at increased risk of infection (abstract). ASAIO J 1995;41(suppl):71.
13. Shaldon S: Biocompatible membranes in acute renal failure (letter). Lancet 1996;347:205.
14. Jacobs C: Membrane biocompatibility in the treatment of acute renal failure: What is the evidence in 1996? Nephrol Dial Transplant 1997;12:38-42.
15. 2-microglobulin levels in chronic hemodialysis patients. J Am Soc Nephrol 1996;7:472-478.
16. Parker TF, Wingard RL, Husni L, Ikizler TA, Parker RA, Hakim RM: Effect of the membrane biocompatibility on nutritional parameters in chronic hemodialysis patients. Kidney Int 1996;49:551-556.
17. Locatelli F, Mastrangelo F, Redaelli B, Ronco C, Marcelli D, La Greca G, Orlandini GC and the Italian Cooperative Dialysis Study Group: Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters. Kidney Int 1996;50:1293-1302.
18. Himmelfarb J, Zaoui P, Holbrook D, Hakim RM: Modulation of granulocyte LAM-1 and MAC-1 during dialysis. A prospective, randomized controlled trial. Kidney Int 1992;41:388-395.
19. Zaoui P, Green W, Hakim RM: Hemodialysis with cuprophane membrane modulates interleukin-2 receptor expression. Kidney Int 1991;39:1020-1026.
20. 2-microglobulin amyloidosis in hemodialysis: A prospective post-mortem study. Kidney Int 1997;51:1928-1932.
21. 2M production and cellular expression. Kidney Int 1990;38:962-968.
22. Memoli B, Libetta C, Rampino T: Hemodialysis related induction of interleukin-6 production by peripheral blood mononuclear cells. Kidney Int 1992;42:320-326.
23. Koda Y, Nishi S, Miyazaki S, Haginoshita S, Sakurabayashi T, Suzuki M, Sakai S, Yuasa Y, Hirasawa Y, Nishi T: Switch from conventional to high-flux membrane reduces the risk of carpal tunnel syndrome and mortality of hemodialysis patients. Kidney Int 1997;52:1096-1101.
24. Locatelli F, Marcelli D, Conte F, Limido A, Malberti F, Spotti D: Morbidity and mortality in ESRD patients on convective or on diffusive extracorporeal treatment. Nephrol Dial Transplant 1997;12:A174.
25. Hakim RM, Held PJ, Stannard DC, Wolfe RA, Port FK, Daugirdas JT, Agodoa L: Effect of the dialysis membrane on mortality of chronic hemodialysis patients. Kidney Int 1996;50:566-570.
26. Woods HF: Evidence for a biocompatibility-independent effect of high-flux dialysis on improved patient survival. Nephrology 1997;3(suppl 1):415.
27. Eknoyan G, Levey AS, Beck GJ, Agodoa LY, Daugirdas JT, Kusek JW, Levin NW, Schulman G: The Haemodialysis (HEMO) study: Rationale for selection of interventions. Semin Dial 1996;9:24-33.
28. HEMO Study Group - prepared by Eknoyan G, Beck GJ, Kusek JW, Levin NW: Progress of the Haemodialysis (HEMO) study (abstract). Nephrology 1997;3(suppl 1):419.